These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10969140)

  • 21. Altered tension cost in (TG(mREN-2)27) rats overexpressing the mouse renin gene.
    Zobel C; Zavidou-Saroti P; Bölck B; Brixius K; Reuter H; Frank K; Diedrichs H; Müller-Ehmsen J; Bloch W; Schwinger RH
    Eur J Appl Physiol; 2007 Jan; 99(2):121-32. PubMed ID: 17063360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
    Peters J; Münter K; Bader M; Hackenthal E; Mullins JJ; Ganten D
    J Clin Invest; 1993 Mar; 91(3):742-7. PubMed ID: 8383701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes.
    Enzminger H; Witte K; Lemmer B
    J Pineal Res; 2001 Oct; 31(3):256-63. PubMed ID: 11589761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enalapril and renal function in hypertensive rats transgenic for mouse renin gene.
    Springate JE; Feld LG; Ganten D
    Hypertension; 1997 Oct; 30(4):868-72. PubMed ID: 9336386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27.
    Montgomery HE; Kiernan LA; Whitworth CE; Fleming S; Unger T; Gohlke P; Mullins JJ; McEwan JR
    J Hypertens; 1998 May; 16(5):635-43. PubMed ID: 9797175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk, renal hypertensive damage, and effects of amlodipine treatment in transgenic TGR(mREN2)27 rats.
    Witte K; Schnecko A; Schmidt T; Voll C; Kränzlin B; Lemmer B
    Gen Pharmacol; 1999 Nov; 33(5):423-30. PubMed ID: 10553884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behaviour of the transgenic (mREN2)27 rat.
    Wilson W; Voigt P; Bader M; Marsden CA; Fink H
    Brain Res; 1996 Aug; 729(1):1-9. PubMed ID: 8874871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian rhythms in the renin-angiotensin system and adrenal steroids may contribute to the inverse blood pressure rhythm in hypertensive TGR(mREN-2)27 rats.
    Lemmer B; Witte K; Schänzer A; Findeisen A
    Chronobiol Int; 2000 Sep; 17(5):645-58. PubMed ID: 11023212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic mapping of soluble guanylyl cyclase genes: implications for linkage to blood pressure in the Dahl rat.
    Azam M; Gupta G; Chen W; Wellington S; Warburton D; Danziger RS
    Hypertension; 1998 Jul; 32(1):149-54. PubMed ID: 9674652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.
    Bishop JE; Kiernan LA; Montgomery HE; Gohlke P; McEwan JR
    Cardiovasc Res; 2000 Jul; 47(1):57-67. PubMed ID: 10869530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
    Gross V; Lippoldt A; Bohlender J; Ganten D; Ganten U; Luft FC
    Exp Nephrol; 1996; 4 Suppl 1():20-6. PubMed ID: 9001893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential development of early hypertension in heterozygous transgenic TGR(mREN2)27 rats.
    Kreutz R; Fernandez-Alfonso MS; Paul M; Peters J
    Clin Exp Hypertens; 1998 Apr; 20(3):273-82. PubMed ID: 9605382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
    Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
    Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.